Drug Approval | October 19, 2024
Granules India receives ANDA approval for Bupropion Hydrochloride ER Tablets
Granules now has a total of 67 ANDA approvals from the USFDA
Granules now has a total of 67 ANDA approvals from the USFDA
He will join in place of Anil Arora, current President- Formulations Operations who will be superannuating in November, 2024
The recent inspection covered both cGMP and PAI processes
Glycopyrrolate Oral Solution is an anticholinergic medication indicated for pediatric patients
Trazodone tablets are indicated for the treatment of major depressive disorder in adults
Against targeted investment of Rs. 3,938 crore, investments worth Rs. 4,024 crores have been made under scheme
Granules India has reported total income of Rs. 1181.92 crores during the period ended June 30, 2024
The company has posted net profit of Rs. 405.31 crores for the Financial Year ended March 31, 2024
Colchicine Capsules are indicated for prophylaxis of gout flares in adult
_256_384.jpg)
This facility manufactures APIs & formulations of oncology and non-oncology products.
Subscribe To Our Newsletter & Stay Updated
